Delivery Order SPE2DX15D2012-SPE2DX24F7SU5
Award Date
11/6/23
Potential Completion Date
11/7/23
Potential Value
$13K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $18,774.53, is for the delivery of the drug Sprycel 100 mg tablets. The award has a completion date of February 28, 2024 and is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $99,951.13 and covers the delivery of pharmaceutical products, including the drug Sprycel 100mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of March 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,285.55 firm fixed-price delivery order is for the pharmaceutical product Sprycel 100 mg Tablet 30s. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $55,285.69 delivery order contract is for the supply of 60-count tablets of Sprycel 50mg, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of September 18, 2024. AmerisourceBergen, through its Corporate Office division, will provide the requested pharmaceutical product to support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,948.33, is a Firm Fixed Price Delivery Order for the supply of Sprycel 100 mg tablets. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for delivery order SPE2DB24FTZ59 issued under an existing $999,999,999 Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and the prime contractor, Amerisourcebergen Drug Corp. The contract is for the supply of pharmaceutical products, including Sprycel 100 mg tablets, to support military healthcare programs. The award has a ceiling value of $29,974.49 and an ultimate completion date of December 29, 2023....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a Firm Fixed Price delivery order for the pharmaceutical product Sprycel 140 mg tablets, with a ceiling value of $12,028.56 and a performance period through April 1, 2024. The contract does not have any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sprycel 140 mg tablets. The award, valued at $5,384.28, is a firm fixed-price delivery order with a completion date of December 16, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including SPRYCEL 70 MG TABLET 60S, valued at $19,604.43. The contract is a delivery order with a firm fixed price, with an ultimate completion date of November 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Sprycel 100 mg tablets. The $16,006.11 firm-fixed-price delivery order contract has a completion date of June 21, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA to provide a comprehensive...